No Prescription |
 |
 | ||
|
Apo Ipravent Nasal Spray Atrovent |
|
| ||
No Prescription » Prescription Drugs 2 » Apo Ipravent Nasal Spray Atrovent APO-IPRAVENT NASAL SPRAY 0.03% is a clear colourless solution and contain 300mcg/mL or ipratropium bromide. The solution is filled into a white opaque plastic bottle closed with a white plastic pump and activator.IndicationsAPO-IPRAVENT NASAL SPRAY is indicated for the treatment and management of perennial rhinitis allergic rhinitis and vasomotor rhinitis when characterised by watery rhinorrhoea.APO-IPRAVENT NASAL SPRAY is also indicated for the symptomatic relief of rhinorrhoea associated with the common cold.Dosage and AdministrationPriming of pump is required before first use.For the treatment and management of perennial rhinitis allergic rhinitis and vasomotor rhinitis when characterised by watery rhinorrhoea:Regular TherapyAdults: Two sprays up each nostril 2 - 3 times a day. Some patients may need 3 - 4 sprays up each nostril during early therapy to obtain maximum benefit during early treatment. Children: 2 sprays up each nostril 2 times a day. Optimal dosage varies with the response of the individual patient.Intermittent TherapyPatients with occasional episodes of watery rhinorrhoea triggered by provocating factors e.g. temperature changes food and exercise should administer 2 - 4 sprays up each nostril prior to exposure.For the symptomatic relief of rhinorrhoea associated with the common coldAdults 0.03% strength: Initial dose: Two sprays into each nostril followed by two further sprays five minutes after the first spray. Subsequent doses (2-3 times per day) two sprays into each nostril. 0.06% strength Two sprays per nostril 3 or 4 times a day Treatment in the common cold has only been studied up to four days. Efficacy and safety of treatment beyond four days have not been established although there has been no evidence of adverse safety effects with longer treatment in perennial rhinitis patients. Buy Apo Ipravent Nasal Spray Atrovent and other Prescription Drugs 2 products online at Medstore. Buy Online at Medstore - Click Here!
About Apo Ipravent Nasal Spray Atrovent: Product Type: Prescription Drugs 2 Apo-Ipravent Nasal Spray ( Atrovent Generic Ipratropium ) Apo-Ipravent Nasal Spray (Atrovent Generic Ipratropium) Atrovent Generic Ipratropium 21mcg 30mL(345 MD) 3 x 345MD(30mL) Atrovent Generic Ipratropium Apo-Ipravent Nasal Spray
View more Prescription Drugs 2 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
